Caution: JavaScript execution is disabled in your browser or for this website. You may not be able to answer all questions in this survey. Please, verify your browser parameters.

CCE Summer School 2022 - Feedback

Feedback Survey for the CCE Summer School 2022





Dear participants, 

we are striving for the improvement of our event and would appreciate your help. We would like to ask you to give us feedback on the CCE Summer School 2022 and to share your suggestions with us.

The survey will be anonymized and your answers will be used for internal purposes only. By participating in the survey, you are accepting these conditions. Please contact the CCE Summer School Organizing Team ( if you have any questions.


How did you hear about the event?

Please assign yourself to the following categories.

How was the event organized? Please rate from 1 (poor) to 5 (excellent). 

Performance on site
Balance between talks and the interactive part (poster session and networking)
Balance between scientific content and spare time
Technical aspects

Do you have suggestions for future speakers, topics or workshops?

Would you recommend the CCE Summer School to others?

Please share any additional comments or suggestions.

Please evaluate the individual presentations. Was the content informative, clear, up-to-date and well presented? Please rate from 1 (poor) to 5 (excellent). 

Monday, October 17th

Introduction of Cancer Core Europe
Next generation cancer precision medicine by proteogenomics (Janne Lethiö)
Functional Precision Medicine (fPM) (Päivi Östling)
AI in cancer research and diagnostic pathology (Frederick Klauschen)
Immunotherapy (Benjamin Besse)
Individualizing Immunotherapy (Dirk Jäger)
1 = poor; 2 = average; 3 = good; 4 = very good; 5 = excellent. 

Tuesday, October 18th

Workshop I: Clinical decision support systems and the CCE molecular tumor board portal (David Tamborero and Richard Baird)
Workshop II: How to set up clinical trials (Irene Brana)
Clinical trials: the added value of translational research (Delia Mezzanzanica)
Personalized treatment in ovarian cancer in the clinical routine - are we there yet? (Elena Iana Braicu)
The role of diet, nutrition and body composition in primary and tertiary cancer prevention (Ellen Kampman)
European cancer burden: perspective in primary prevention (Jérome Foucaud)
The role of physical activity in primary and tertiary cancer prevention (Karen Steindorf)
1 = poor; 2 = average; 3 = good; 4 = very good; 5 = excellent. 

Wednesday, October 19th

Patient involvement and Ethics (Eva Winkler)
Hereditary Gastric Cancer: Clinical and molecular aspects (Carla Oliveira)
Gene regulation in breast cancer (Ana Teresa Maia)
Hereditary breast cancer - treatment and prevention (Svetlana Lagercrantz)
1 = poor; 2 = average; 3 = good; 4 = very good; 5 = excellent. 

Thursday, October 20th

On the cross roads of translational research and computational science: making impact (Emile Voest)
Precision immuno-oncology for advanced non-small cell lung cancer patients (Fabrice Barlesi)
Precision Medicine for cancer patients - yesterday and tomorrow (Jonas Berg)
Biology-guided precision medicine in rare cancers (Stefan Fröhling)
Doing research in the real world: what we learned from COVID-19 (Giovanni Apolone)
Health economics (Michael Schlander)
Artificial intelligence-based biomarkers in precision oncology (Jakob Kather)
1 = poor; 2 = average; 3 = good; 4 = very good; 5 = excellent. 

Friday, October 21th

Immune function of extracellular matrix in TME and bone marrow (Mario Paolo Colombo)
Adoptive T cell therapy using TILs and lessons from the tumor microenvironment (George Coukos)
Molecular imaging and theranostics in oncology (Wim Oyen)
AI in medical imaging for developing new cancer biomarkers (Raquel Pérez-López)
1 = poor; 2 = average; 3 = good; 4 = very good; 5 = excellent.